E-drug: Double standards in pharmaceutical advertising
----------------------------------------------------------
Dear Colleagues,
Any recent papers you know of with respect to probable/potential/confirmed
double standards in pharmaceutical advertisements between developed and
developing countries? We may have come across one such example locally
and would like to review the pertinent literature for a potential piece
on the subject.
Thanks in advance,
Rodolfo J Dennis, MD, MSc
Head, Clinical Epidemiology and Biostatistics Unit
School of Medicine, Pontificia Universidad Javeriana
Bogota, Colombia
rdennis@javercol.javeriana.edu.co
[Note from moderator: The topic has probably been discussed before on E-drug
and there are several good publications from HAI and other about it. Howver,
Rodolfo asks for some recent experience. I'm sure we have updated
subscribers who can help him! KM]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.